Latest Articles

  • Oral plaques and dysphagia in a young man
    Amber S. Tully, MD and Carol Dao, MD
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 594-596; DOI: https://doi.org/10.3949/ccjm.78a.10150

    A 23-year-old man presents with oral plaques, a sore throat, dysphagia, malaise, and weight loss. What is the most likely diagnosis?

  • What is the optimal duration of bisphosphonate therapy?
    What is the optimal duration of bisphosphonate therapy?
    Susan M. Ott, MD
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 619-630; DOI: https://doi.org/10.3949/ccjm.78a.11022

    It is reasonable to stop bisphosphonates after 5 years of use and then to follow patients with markers of bone turnover.

  • Hepatic encephalopathy: Suspect it early in patients with cirrhosis
    Jamilé Wakim-Fleming, MD, FACG
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 597-605; DOI: https://doi.org/10.3949/ccjm.78a10117

    Prompt identification and treatment are essential, since the prognosis worsens rapidly once overt encephalopathy develops.

  • Venous thromboembolism: What to do after anticoagulation is started
    Scott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACP
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175

    Three issues need to be addressed: the length of therapy, measures to prevent postthrombotic syndrome, and a basic workup for possible underlying malignancy.

  • Allergy blood testing: A practical guide for clinicians
    Roxana I. Siles, MD and Fred H. Hsieh, MD
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 585-592; DOI: https://doi.org/10.3949/ccjm.78a.11023

    These tests can confirm the diagnosis of an allergic disorder, supplementing the clinical history. They are particularly useful when skin testing cannot or should not be done.

  • When to stop treating the bones
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 563; DOI: https://doi.org/10.3949/ccjm.78b.11009

    Don’t let the argument about how long to treat osteoporosis with bisphosphonate drugs stand in the way of initiating therapy in patients at risk of fracture.

  • Unmasking gastric cancer
    Faysal Altahawi, Abdul Hamid Alraiyes, MD and M. Chadi Alraies, MD, FACP
    Cleveland Clinic Journal of Medicine September 2011, 78 (9) 606-608; DOI: https://doi.org/10.3949/ccjm.78a.10129

    Screening with diagnostic imaging may be justified in high-risk groups, although the issue is debatable.

  • Prognostic Significance of PD2i in Heart Failure Patients
    Iwona Cygankiewicz, MD, PhD, Wojciech Zareba, MD, PhD, Scott McNitt, MS and Antoni Bayes de Luna, MD
    Cleveland Clinic Journal of Medicine August 2011, 78 (8 suppl 1) S91;
  • Sympathovagal Imbalance Assessed by Heart Rate Variability Correlates With Percent Body Fat and Skeletal Muscle, Independent of Body Mass Index
    David Martinez Duncker R., MD, PhD, Martha Elva Rebolledo Rea, MD,MSc, Ernesto González Rodríguez, MD,MSc, David M. Duncker Rebolledo, MD and Martha E.M. Duncker Rebolledo, MS
    Cleveland Clinic Journal of Medicine August 2011, 78 (8 suppl 1) S91a;
  • Prevalence of Anxiety and Type D Personality in an Outpatient ICD Clinic
    Leo Pozuelo, MD, Melanie Panko, RN, Betty Ching, RN, Denise Kosty-Sweeney, RN, Scott Bea, PhD, Karen Broer, PhD, Julie Thornton, MS, Kathy Wolski, MPH, Karl-Heinz Ladwig, MD, Sam Sears, PhD, Suzanne Pedersen, PhD, Johan Denollet, PhD and Mina K. Chung, MD
    Cleveland Clinic Journal of Medicine August 2011, 78 (8 suppl 1) S81;

Pages